Investors in Ar

GB & Partners is Hungary's largest independent venture and private equity fund management company, supporting portfolio companies with active operational involvement to ensure high returns and security for investors. They specialize in ambitious, game-changing ventures, providing strategic, sales, and professional support, contributing to the growth and prosperity of their investments. As a full member of Invest Europe, GB & Partners manages nearly HUF 80 billion in assets, covering a wide range of industries and geographical areas, achieving significant growth and record sales.

Vespucci Partners is a Budapest-based venture capital fund focused on finding and supporting Central European startups with disruptive products and global market potential. They provide more than just financial backing, offering smart capital, portfolio management expertise, guidance, and a strong network for international expansion. With a fund size of 41 million EUR, Vespucci Partners targets Seed and Series A investments ranging from 600k to 4.5 million EUR, aiming to help startups achieve long-term success through a combination of sustainability principles, strategic support, and extensive industry experience.

SUP.VC is a corporate innovation company in Azerbaijan that supports the startup ecosystem by organizing events, implementing projects, and providing mentorship, investment connections, and product development. Collaborating with international brands like Amazon Web Services and Techstars Startup Weekend, SUP.VC offers educational initiatives, strategic partnerships, and community support to foster innovation and growth. With a strong track record of completed projects, satisfied clients, and numerous events, SUP.VC empowers emerging ventures for success through a holistic approach to entrepreneurship.

3LB Seed Capital is a privately owned holding company focused on seed investments in Italian startups form emerging sectors. 3LB Seed Capital enters into the start-ups equity essentially in the initial phases of their developments, more often as the first investor outside the circle of the founders. Our individual investments are generally sized between €30k and €60k; we invest in young entrepreneurs that really show us their strong focus and resilience in supporting their projects & ideas, and we establish with them a "business partners" relationship proper to angel investors. For larger investments, within the range of €500k, we share the risk with other investing partners, both individuals or investing syndicates and club-deals. Occasionally, when we have the opportunity to co-invest with our network of contacts in companies ahead in their development path, we follow with more significant funding rounds, beyond the threshold of 1 M€.

Claris Ventures SGR makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence. We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence. Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing" (or the relevant translation).

The principals of AME Ventures have a strong track record in early stage investiments, with over 40 companies in many sectors and many countries, with several IPOs and trade sales. All sectors are considered for investment, main driver of selection is growth potential. Current areas of focus are very diverse: service sector companies, technology applied to design companies and renewable energy, in particular solar. Investment can be minority or majority holdings. Currently there is a preference for majority holdings where AME Ventures principals can be actively involved.

We partner with stellar entrepreneurs to realize their unique intuitions and reach their goals, inspired by values. Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and our advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources. We are sector agnostic and target innovative opportunities around the world. We share goals and passion with founders and look to connect them with our wide international network to bridge their expansion domestically as well as overseas. Investment Criteria Focus on Early Stage and Growth phases rounds for companies offering innovative products / services operating within a large addressable market. Target investments should ideally have potential for international expansion.

Genextra is a privately owned holding company with investments in early-stage life science companies. Our mission is to identify innovative research in life science and to advance novel therapies and tools by creating successful business initiatives.

Invent Innovation Ventures is a Rome-based seed capital company. It specialises in innovation consulting, business administration, development and financing of high-tech projects and start-ups creation.

Delirus Capital is a founder-focused investment firm that provides early-stage funding to exceptional founders across Europe, the UK, and the US.Delirus Capital helps to invset in consumer-focused businesses where it could draw on its branding and community-building experience.

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.

Pi Campus was established with the profits generated by Marco Trombetti, Isabelle Andrieu, and Gianluca Granero from their previous businesses. Initially, it was the investment arm of Translated, a translation service that pioneered the use of artificial intelligence to help professional translators. After a few years, things started growing very fast and the VC firm was created. We invest in Europe and the US, without any constraints regarding how much and when to invest. Nor do we plan to exit in advance. We invest mostly in AI, but if your startup is growing incredibly fast, it would be our pleasure to meet you anyway.